Payer Mix
Payer mix is the distribution of an agency's patients and revenue across payer types: traditional Medicare fee-for-service, Medicare Advantage, Medicaid, commercial insurance, and private pay. Because reimbursement per episode varies dramatically by payer while the cost of delivering a visit does not, payer mix is one of the strongest predictors of an agency's margin and a lever leadership can manage deliberately rather than inherit by accident.
Why payer mix drives margin
Traditional Medicare pays episodically under PDGM (the Patient-Driven Groupings Model), with 30-day payment periods that generally represent an agency's strongest rates. Medicare Advantage (MA) plans frequently pay per-visit rates that run well below equivalent episodic payment, often with prior authorization requirements and visit caps that add administrative cost on top. Medicaid and some commercial rates vary by state and contract. Meanwhile, the clinician's drive time, visit length, documentation, and supplies cost roughly the same regardless of who pays. Two agencies with identical census and identical clinical operations can have completely different financial results purely on mix, which is why payer mix belongs on the same dashboard as census and visits.
How to measure your payer mix
Look at mix three ways, because they tell different stories:
- Census mix: share of active patients by payer, which drives staffing and scheduling load
- Revenue mix: share of dollars by payer, which usually skews more heavily toward Medicare FFS
- Margin mix: contribution by payer after direct costs, which reveals which business is actually worth growing
Track admissions by payer monthly, not just the standing census, since admissions show where your mix is heading. An agency whose census is 60% Medicare FFS but whose new admissions are 45% is drifting, and the revenue impact arrives two quarters later.
The Medicare Advantage shift
More than half of Medicare beneficiaries are now enrolled in Medicare Advantage plans, and the share has grown steadily for years. That makes refusing MA business increasingly untenable in most markets: the referrals simply are the patient population. The workable strategy is selectivity and negotiation rather than avoidance. Know your cost per visit and per episode so you can identify which contracts clear it, push for episodic or case-rate structures instead of straight per-visit rates where possible, and renegotiate or exit chronically underwater contracts. Some agencies also pursue MA plans' value-based arrangements, where readmission performance earns better economics than the base rate alone.
Managing payer mix intentionally
Payer mix is the sum of many small decisions: which referral sources liaisons call on, which contracts intake accepts, and how capacity is allocated when the schedule is tight. Point those decisions in one direction. Give liaisons targets that reflect margin, not just admission counts, so a quarter filled with underwater per-visit business does not count as a win. Set non-admit criteria that weigh authorization burden and rates against current capacity. Review every managed care contract on a calendar, not just at renewal pressure. The pitfall to avoid is chasing census for its own sake; growth in negative-margin business makes the agency bigger and weaker at the same time.
Frequently asked questions
What is a good payer mix for a home health agency?
There is no universal target, because markets differ in MA penetration and Medicaid rates. As a rule, agencies protect their traditional Medicare share where they can, since it typically carries the strongest per-episode economics, while building a selective MA book at negotiated rates that clear their cost per visit.
Should we ever decline referrals from low-paying payers?
Sometimes, and it should be a policy decision rather than an intake improvisation. If a contract pays below your cost per visit and capacity is constrained, accepting that referral displaces better business. That said, weigh relationship effects: a hospital sending you profitable Medicare referrals may expect you to take its MA patients too.
How often should we review payer mix?
Monthly for the numbers, with admissions by payer as the leading indicator, and at least annually for each managed care contract's actual performance against cost. Quarterly is a sensible cadence for deciding whether referral targeting or contracting priorities need to shift.